Author: Stefani Kim

Purifying Gentamicin Could Reduce Hearing Loss Risk

Gentamicin is used in US hospitals to treat a variety of bacterial infections, including infections in newborns and in other susceptible patients, such as those with cystic fibrosis. Yet researchers estimate that up to 20% of patients who are treated with it experience some degree of irreversible hearing loss.

Read More

Researchers Design Nasolaryngoscopy Hood

The COVID-19 pandemic has continued to cause dramatic shifts in the practice of otolaryngology. Even with standard precautions such as physical distancing and wearing personal protective equipment (PPE), aerosol-generating procedures such as nasolaryngoscopy (a commonly performed in-office procedure in which a soft, flexible fiber-scope is passed through the nose and into the throat) and intranasal instrumentation were determined to carry a risk of potential transmission if not adequately protected.

Read More

Frequency Therapeutics to Host Virtual Q&A On Jan. 19

Researchers and clinicians, along with company executives, will discuss current interventions for the treatment of acquired sensorineural hearing loss (SNHL), unmet medical needs for hearing loss patients, and the potential of FX-322 to “transform the current standard of care.”

Read More

Early Start to Music Training Key to Developing Skill

Could there be more to mastering music? Is there, as some have suggested, a developmental period early in life when the brain is especially receptive to musical training? The answer, according to new research published in the journal, “Psychological Science,” is probably not.

Read More

‘Earable Computing’ New Focus of Research

CSL’s Systems and Networking Research Group (SyNRG) is defining a new sub-area of mobile technology that they call “earable computing.” The team believes that earphones will be the next significant milestone in wearable devices, and that new hardware, software, and apps will all run on this platform

Read More